Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7962222 | 1.00 | UNG (1.00) | UNGGPR84 | |
| SCHEMBL7950536 | 1.00 | UNG (1.00) | UNGGPR84 | |
| SCHEMBL3497866 | 0.94 | UNG (0.90) | UNGGPR84 | |
| SCHEMBL7951357 | 0.82 | UNG (1.00) | UNGGPR84 | |
| SCHEMBL7962219 | 0.82 | UNG (1.00) | UNGGPR84 | |
| SCHEMBL7959022 | 0.78 | UNG (0.64) | UNGGPR84 | |
| SCHEMBL7951210 | 0.77 | UNG (0.62) | UNG | |
| SCHEMBL7951048 | 0.76 | UNG (0.75) | UNGGPR84 | |
| SCHEMBL2391508 | 0.75 | ESR1 (0.61) | UNG | |
| SCHEMBL294666 | 0.75 | ESR1 (0.61) | UNG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170216428-A1 | VACCINE FOR TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION | AGENUS INC. (US) | 2017-08-03 | — | — | US | disclosed |
| EP-2289547-B1 | Vaccine for treatment and prevention of herpes simplex virus infection | AGENUS INC (US) | 2015-12-16 | — | — | EP | disclosed |
| US-20140105854-A1 | VACCINE FOR TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION | AGENUS INC. (US) | 2014-04-17 | — | — | US | disclosed |
| US-8541002-B2 | Vaccine for treatment and prevention of herpes simplex virus infection | AGENUS INC. (US) | 2013-09-24 | — | — | US | disclosed |
| US-20110059041-A1 | Vaccine for treatment and prevention of herpes simplex virus infection | AGENUS INC. | 2011-03-10 | — | — | US | disclosed |
| EP-2289547-A1 | Vaccine for treatment and prevention of herpes simplex virus infection | Antigenics Inc. (US) | 2011-03-02 | — | — | EP | disclosed |
| EP-1670507-A4 | VACCINE FOR TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION | ANTIGENICS INC (US) | 2007-10-17 | — | — | EP | disclosed |
| EP-1670507-A2 | VACCINE FOR TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION | Antigenics Inc. (US) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005028496-A2 | VACCINE FOR TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION | ANTIGENICS, INC. (US) | 2005-03-31 | — | — | WO | disclosed |
| US-6177437-B1 | VIRICIDES | UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER | 2001-01-23 | — | — | US | disclosed |